Cargando…

Effects of erythropoietin receptors and erythropoiesis-stimulating agents on disease progression in cancer

Erythropoiesis-stimulating agents (ESAs) increase red blood cell (RBC) production in bone marrow by activating the erythropoietin receptor (EpoR) on erythrocytic-progenitor cells. Erythropoiesis-stimulating agents are approved in the United States and Europe for treating anaemia in cancer patients r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aapro, M, Jelkmann, W, Constantinescu, S N, Leyland-Jones, B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2012
Materias:	Minireview
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3314780/ https://www.ncbi.nlm.nih.gov/pubmed/22395661 http://dx.doi.org/10.1038/bjc.2012.42

Ejemplares similares

Networking erythropoiesis
por: Kerenyi, Marc A., et al.
Publicado: (2010)

Association between high-dose erythropoiesis-stimulating agents, inflammatory biomarkers, and soluble erythropoietin receptors
por: Inrig, Jula K, et al.
Publicado: (2011)

Erythropoietin and the Regulation of Erythropoiesis
por: Mc Phedran, Peter
Publicado: (1971)

Progress in detecting cell-surface protein receptors: the erythropoietin receptor example
por: Elliott, Steve, et al.
Publicado: (2013)

EGFR-targeting drugs in combination with cytotoxic agents: from bench to bedside, a contrasted reality
por: Milano, G, et al.
Publicado: (2008)

Erythropoiesis-Stimulating Agents in the Management of Anemia in Chronic Kidney Disease or Cancer: A Historical Perspective
por: Aapro, Matti, et al.
Publicado: (2019)

Different effects of granulocyte colony-stimulating factor and erythropoietin on erythropoiesis
por: Chen, Tzu-Lin, et al.
Publicado: (2018)

Neuronal nitric oxide synthase is required for erythropoietin stimulated erythropoiesis in mice
por: Lee, Jeeyoung, et al.
Publicado: (2023)

Iron modulation of erythropoiesis is associated with Scribble-mediated control of the erythropoietin receptor
por: Khalil, Shadi, et al.
Publicado: (2018)

Beyond Erythropoiesis: Emerging Metabolic Roles of Erythropoietin
por: Woo, Minna, et al.
Publicado: (2014)

Pharmacovigilance in practice: erythropoiesis-stimulating agents
por: Hedenus, Michael, et al.
Publicado: (2014)

Erythropoietin: multiple targets, actions, and modifying influences for biological and clinical consideration
por: Broxmeyer, Hal E.
Publicado: (2013)

In Vivo Regulation of Erythropoiesis by Chemically Inducible Dimerization of the Erythropoietin Receptor Intracellular Domain
por: Suzuki, Norio, et al.
Publicado: (2015)

Study of the erythropoiesis activity of nano-encapsulated forms of erythropoietin
por: Khasenbekova, Zhanagul, et al.
Publicado: (2014)

Erythropoiesis stimulating agents: approaches to modulate activity
por: Sinclair, Angus M
Publicado: (2013)

Altitude Pre-Acclimatization with an Erythropoiesis-Stimulating Agent
por: Heldeweg, Micah L. A., et al.
Publicado: (2023)

Erythropoiesis-stimulating agents: benefits and risks in supportive care of cancer
por: Melosky, B.L.
Publicado: (2008)

Biomarkers of clinical benefit for anti-epidermal growth factor receptor agents in patients with non-small-cell lung cancer
por: Pallis, A G, et al.
Publicado: (2011)

Quantitative assessment of minimal effective concentration of erythropoiesis-stimulating agents
por: Yan, X, et al.
Publicado: (2013)

Erythropoiesis-Stimulating Agent Hyporesponsiveness and Adverse Outcomes: Guilty as Charged?
por: Wish, Jay B.
Publicado: (2020)

Inflammation and Erythropoiesis-Stimulating Agent Hyporesponsiveness: A Critical Connection
por: Shah, Hitesh H., et al.
Publicado: (2020)

Use of erythropoiesis-stimulating agents in obese hemodialysis patients
por: Park, Sun-Hee
Publicado: (2018)

Treatment of renal anemia: Erythropoiesis stimulating agents and beyond
por: Biggar, Patrick, et al.
Publicado: (2017)

Tips for erythropoiesis-stimulating agent treatment of renal anemia
por: Tomosugi, Naohisa, et al.
Publicado: (2019)

Erythropoiesis-Stimulating Agent Treatment in Patients With COVID-19
por: Fishbane, Steven, et al.
Publicado: (2020)

Parathyroidectomy Improves the Consumption of Erythropoiesis-Stimulating Agents in Hemodialysis Patients
por: Lee, Yu-Ting, et al.
Publicado: (2022)

Erythropoietin-directed erythropoiesis depends on serpin inhibition of erythroblast lysosomal cathepsins
por: Dev, Arvind, et al.
Publicado: (2013)

Erythropoietin-directed erythropoiesis depends on serpin inhibition of erythroblast lysosomal cathepsins
por: Dev, Arvind, et al.
Publicado: (2014)

A Biomathematical Model of Human Erythropoiesis under Erythropoietin and Chemotherapy Administration
por: Schirm, Sibylle, et al.
Publicado: (2013)

Impact of Erythropoietin Production by Erythroblastic Island Macrophages on Homeostatic Murine Erythropoiesis
por: Perron-Deshaies, Genève, et al.
Publicado: (2020)

Molecular Insights into the Oxygen-Sensing Pathway and Erythropoietin Expression Regulation in Erythropoiesis
por: Tomc, Jana, et al.
Publicado: (2021)

Outcomes of erythropoiesis-stimulating agents in cancer patients with chemotherapy-induced anemia
por: Pashos, Chris L., et al.
Publicado: (2011)

Erythropoiesis stimulating agents and reno-protection: a meta-analysis
por: Elliott, Steve, et al.
Publicado: (2017)

Selenium Associates With Response to Erythropoiesis-Stimulating Agents in Hemodialysis Patients
por: Yasukawa, Minoru, et al.
Publicado: (2022)

Effect of erythropoietin-stimulating agent on uremic inflammation
por: Tanaka, Yuri, et al.
Publicado: (2012)

Erythropoiesis-stimulating Agents and Anemia in Patients with Non-dialytic Chronic Kidney Disease
por: Kim, Sun Moon, et al.
Publicado: (2016)

Erythropoietin stimulating agents in the management of anemia of chronic kidney disease
por: Hayat, Amir, et al.
Publicado: (2008)

Effect of Erythropoiesis-Stimulating Agents on Blood Pressure in Pre-Dialysis Patients
por: Suttorp, Marit M., et al.
Publicado: (2013)

Erythropoiesis-stimulating agent resistance and mortality in hemodialysis and peritoneal dialysis patients
por: Suttorp, Marit M, et al.
Publicado: (2013)

Erythropoietin and IGF-1 signaling synchronize cell proliferation and maturation during erythropoiesis
por: Kadri, Zahra, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_86eq8fallpudqt369lc8lr1q55